References
- Jacobs PA, Strong JA. A case of human intersexuality having a possible XXY sex-determining mechanism. Nature. 1959;183:302–303.
- Lanfranco F, Kamischke A, Zitzmann M, et al. Klinefelter’s syndrome. Lancet. 2004;364(9430):273–283.
- Groth KA, Skakkebaek A, Høst C, et al. Klinefelter syndrome – a clinical update. J Clin Endocrinol Metab. 2013;98(1):20–30.
- Frühmesser A, Kotzot D. Chromosomal variants in Klinefelter syndrome. Sex Dev. 2011;5:109–123.
- Batista RL, Costa EMF, Rodrigues AS, et al. Androgen insensitivity syndrome. A review. Arch Endocrinol Metab. 2018;62(2):227–235.
- Śmigiel R, Biela M, Szmyd K, et al. Rapid whole-exome sequencing as a diagnostic tool in a neonatal/pediatric intensive care unit. JCM. 2020;9(7):2220.
- Jarzabek K, Koda M, Chrusciel M, et al. Features of the fetal gonad in androgen synthesis in the postpubertal testis are preserved in complete androgen insensitivity syndrome due to a novel genetic splice site donor variant in androgen receptor gene intron 1. J Steroid Biochem Mol Biol. 2019;193:105420.
- Smigiel R, Sherman DL, Rydzanicz M, et al. Homozygous mutation in the Neurofascin gene affecting the glial isoform of Neurofascin causes severe neurodevelopment disorder with hypotonia, amimia and areflexia. Hum Mol Genet. 2018;27(21):3669–3674.
- Manuel M, Katayama KP, Jones HW. The age of occurrence of gonadal tumors in intersex patients with a Y chromosome. Am J Obstet Gynecol. 1976;124(3):293–300.
- Eyben F. v. Laboratory markers and germ cell tumors. Cr Rev Clin Lab Sci. 2003;40(4):377–427.
- Valente U, Vinanzi C, Dipresa S, et al. Is there any clinical relevant difference between non mosaic Klinefelter syndrome patients with or without androgen receptor variations? Sci Rep. 2017;7(1):3358.
- Girardin CM, Deal C, Lemyre E, et al. Molecular studies of a patient with complete androgen insensitivity and a 47,XXY karyotype. J Pediatr. 2009;155:439–443.
- Weber Silva DM, Bagatin de Souza Moreira B. Complete androgen insensitivity syndrome (CAIS) and karyotype 47, XXY, with Sertoli–Leydig cell tumor: description of a rare case. Ann Clin Diabetes Endocrinol. 2019;2(1):1011.
- Lanciotti L, Cofini M, Leonardi A, et al. Different clinical presentations and management in complete androgen insensitivity syndrome (CAIS). IJERPH. 2019;16(7):1268.
- Farage M, Maibach H. Lifetime changes in the vulva and vagina. Arch Gynecol Obstet. 2005;273(4):195–202.
- Lteif A, Javed A. Development of the human breast. Semin Plast Surg. 2013;27(01):5–12.
- Chang S, Skakkabaek A, Gravholt CH. Klinefelter syndrome and medical treatment: hypogonadism and beyond. Hormones. 2015;14(4):531–548.
- Döhnert U, Wünsch L, Hiort O. Gonadectomy in complete androgen insensitivity syndrome: why and when? Sex Dev. 2017;11:171–174.
- Frank GR. Role of estrogen and androgen in pubertal skeletal physiology. Med Pediatr Oncol. 2003;41(3):217–221.
- Cools M, Looijenga L. Update on the pathophysiology and risk factors for the development of malignant testicular germ cell tumors in complete androgen insensitivity syndrome. Sex Dev. 2017;11(4):175–181.
- Bertelloni S, Meriggiola MC, Dati E, et al. Bone mineral density in women living with complete androgen insensitivity syndrome and intact testes or removed gonads. Sex Dev. 2017;11(4):182–189.
- Hughes IA, Deeb A. Androgen resistance. Best Pract Res Cl En. 2006;20(4):577–598.
- Kusumi M, Mitsunami M, Onoue H, et al. Complete androgen insensitivity syndrome and anti-Müllerian hormone levels before and after laparoscopic gonadectomy. Gynecol Minim Invasive Ther. 2017;6(3):126–128.